Saberry®

Saberry® is a proprietary and patented extract of fruits of Emblica officinalis. (synonymous with Phyllanthus emblica), more commonly known as amla. Saberry® is standardized to contain a minimum of 10% β‐glucogallin. Saberry® is the result of efforts to prepare an authenticated amla extract, standardized using a valid biomarker, β-glucogallin. In‐house studies revealed that β-glucogallin is a more powerful antioxidant molecule, as compared to ascorbic acid. "NATURAL SUGAR BALANCE" Lipid Metabolism • A potent inhibitor of a-amylase, a-glucosidase, aldose reductase and DPP-IV enzymes. • Superior efficacy in reducing fasting blood sugar (FBS), post prandial blood sugar (PPPBS) and Glycated hemoglobin (HbA1C). • Glucose and lipid lowering effect comparable to metformin (0.5g) at 1g and better than metformin at 2g. • Helps reduce oxidative stress by increasing the levels antioxidant enzymes (catalase and GSH) and decreasing MDA, GPX, SOD in NAFLD patients when compared to baseline. • Safe and well tolerated upto 2g • Clinically validated 18 patents 9 publications 1 clinical studies 10% strength www.saberry.com